Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Recruiting

Evaluation of CMV/EBV-CMI in Haploid HSCT

NCT06554197

Conditions: Cytomegalovirus Infections, DNA Virus Infections, Epstein-Barr Virus Infections, +5 more
Locations: First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

NCT06503094

Conditions: B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs

NCT06500767

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +13 more
Locations: Ospedale Sant'Anna Turin, TO, Italy

View Trial Details

Recruiting

Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

NCT06445088

Conditions: Carcinoma, DNA Virus Infections, Disease, +20 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

ZhongShan City People's Hospital Zhongshan, Guangdong, China

The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Recruiting

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT04422366

Conditions: AIS, CIN1, CIN2, +45 more
Locations: Liuzhou center for disease control and prevention Liuzhou, Guangxi, China

View Trial Details

Recruiting

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

NCT06326294

Conditions: Blood-Borne Infections, CIN 2/3, Communicable Diseases, +19 more
Locations: INSMozambique Maputo, Mozambique

View Trial Details

Recruiting

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

NCT05371353

Conditions: CIN1, CIN2, CIN3, +36 more
Locations: Yangchun Center For Disease Prevention And Control Yangchun, Guangdong, China

Center for Disease Control and Prevention Mianyang, Sichuan, China

View Trial Details

Recruiting

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

NCT05027776

Conditions: CIN1, CIN2, CIN3, +36 more
Locations: Center for Disease Control and Prevention Mianyang, Sichuan, China

View Trial Details

Recruiting

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

NCT05625633

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +15 more
Locations: University of Utah Midvalley Health Center Salt Lake City, Utah, United States

VA Salt Lake City Health Care System Salt Lake City, Utah, United States

View Trial Details

Recruiting

Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens

NCT06327568

Conditions: Anal Cancer, Anal Intraepithelial Neoplasia 1, Anal Intraepithelial Neoplasia 2, +27 more
Locations: European Institute of Oncology Milan, Italy

View Trial Details

Tumor Virus Infections

Tumor Virus Infections trial results

Related conditions